Healthcare & Life Sciences
SynsoryBio
United States
seed
seed
Stage
About
SynsoryBio develops protein therapeutics engineered to sense their tissue context and activate only in diseased tissue, with the goal of expanding the therapeutic window of potent drugs. The platform is intended for applications including oncology and autoimmune disorders.
Explore SynsoryBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.